Exploring the Global Medical Isotopes Market in 2024: Forecasted Growth, Market Size, and Key Factors

Medical isotopes are radioisotopes used in medicine that emit positrons or gamma rays for diagnostic purposes. These isotopes help visualize and target specific tissues or abnormalities within the body such as to evaluate heart function, assess blood flow to the heart muscle, and diagnose coronary artery disease.

Sizing and Forecast
 The medical isotopes market size has grown strongly in recent years. It will grow from $6.31 billion in 2023 to $6.80 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%.  The growth in the historic period can be attributed to the rising incidence of chronic diseases, expansion of the pharmaceutical industry, advancements in cancer treatment, demand for diagnostic imaging, and advancements in nuclear medicine

The medical isotope market size is expected to see strong growth in the next few years. It will grow to $9.21 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%.  The growth in the forecast period can be attributed to public health initiatives, partnerships and collaborations, investment in infrastructure, a shift towards personalized medicine, a growing geriatric population, regulatory changes, and standards. Major trends in the forecast period include growth in radiopharmaceuticals, adoption of cyclotron and generator technologies, focus on supply chain resilience, integration of artificial intelligence (AI), and advancements in positron emission tomography (PET) imaging.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/medical-isotopes-global-market-report

Segmentation & Regional Insights
The medical isotopes market covered in this report is segmented –

1) By Product Type: Stable Isotopes, Radio Isotopes
2) By Production Method: Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
3) By Application: Nuclear Therapy, Equipment Radioactive Source, Diagnosis
4) By End Use: Hospitals, Diagnostic Centers, Research Institutes

North America was the largest region in the medical isotopes market in 2023. The regions covered in the medical isotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15853&type=smp

Major Driver Impacting Market Growth
The rising cancer and heart disease rates are expected to propel the growth of the medical isotope market going forward. Cancer and heart disease rates refer to the frequency of new cases and prevalence of these diseases within a population over a specified period, providing insights into public health trends and the effectiveness of preventive measures. The increasing prevalence of cancer and heart disease correlates with the widespread sedentary lifestyle encouraged by modern technology and desk-bound occupations, resulting in reduced levels of physical activity. Medical isotopes are used to diagnose and treat cancer and heart disease through imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans and therapies such as radiation therapy and radioactive stents. For instance, in October 2022, according to the World Heart Federation, a Switzerland-based cardiovascular community, the number of cardiovascular disease (CVD) deaths, including heart disease, is projected to rise from an estimated 18.9 million in 2020 to over 22.2 million in 2030. Additionally, in January 2021, according to the American Cancer Society, a US-based voluntary health organization, there were an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States in 2021, an increase from 1.8 million new cancer cases diagnosed and 606,520 cancer deaths reported in 2020. Therefore, the rising cancer and heart disease rates are driving the growth of the medical isotope market.

Key Industry Players
Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien München AG (ITM), Eczacıbaşı-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotóp, Coquí RadioPharmaceuticals Corp., Jubilant DraxImage Inc., Positron Corporation

The medical isotopes market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company  
Twitter: https://twitter.com/tbrc_info  
Facebook: https://www.facebook.com/TheBusinessResearchCompany  
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  
Blog: https://blog.tbrc.info/  
Healthcare Blog: https://healthcareresearchreports.com/  
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model